Zydus Cadila's MD is new IPA president
This article was originally published in Scrip
Executive Summary
Pankaj R Patel, chairman and managing director of Zydus Cadila, has taken over as president of the Indian Pharmaceutical Alliance (IPA), which represents leading domestic companies. Mr Patel, previously vice-president of the IPA, succeeds Sudhir Mehta, chairman of the Torrent group. Dr Prakash A Mody, chairman and managing director of Unichem Laboratories, takes over as vice-president. Formed with eight members in November 1999, the IPA now has 12 Indian member companies that account for more than one-third of the country’s pharmaceutical exports.
You may also be interested in...
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.
Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA
Plus deals involving Incyte/CMS, Biocytogen/ABL, Bharat/Biofabri/Bilthoven, Dr. Reddy’s/Pharmazz, Veeda/Heads, Sosei Heptares/GSK, BioGeometry/Sanyou, Ono/Sibylla and Teijin/BioProjet
Astellas CStO Pearson: We’re Not Short Of Opportunities To Compensate For LOEs
Astellas’ chief strategy officer, Adam Pearson, talks to Scrip about the company’s launch execution thrust for key therapies ahead of the loss of exclusivity for Xtandi and also deal-making appetite and choices, including the Iveric Bio buyout and walking away from the collaboration with Cartesian Therapeutics.